{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:10:36Z","timestamp":1790766636336,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2014_0686"],"award-info":[{"award-number":["2014_0686"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["537-2015"],"award-info":[{"award-number":["537-2015"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["2015B7M39T_004"],"award-info":[{"award-number":["2015B7M39T_004"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2015LFPNMN"],"award-info":[{"award-number":["2015LFPNMN"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2015B7M39T_004"],"award-info":[{"award-number":["2015B7M39T_004"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Banca del Monte Lombarda, Italy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Prostate cancer (PC) is one of the leading causes of death in males. Available treatments often lead to the appearance of chemoresistant foci and metastases, with mechanisms still partially unknown. Within tumour mass, autophagy may promote cell survival by enhancing cancer cells tolerability to different cell stresses, like hypoxia, starvation or those triggered by chemotherapic agents. Because of its connection with the apoptotic pathways, autophagy has been differentially implicated, either as prodeath or prosurvival factor, in the appearance of more aggressive tumours. Here, in three PC cells (LNCaP, PC3, and DU145), we tested how different autophagy inducers modulate docetaxel-induced apoptosis. We selected the mTOR-independent disaccharide trehalose and the mTOR-dependent macrolide lactone rapamycin autophagy inducers. In castration-resistant\u00a0PC (CRPC) PC3 cells, trehalose specifically prevented intrinsic apoptosis in docetaxel-treated cells. Trehalose reduced the release of cytochrome\n                    <jats:italic>c<\/jats:italic>\n                    triggered by docetaxel and the formation of aberrant mitochondria, possibly by enhancing the turnover of damaged mitochondria via autophagy (mitophagy). In fact, trehalose increased\n                    <jats:italic>LC3<\/jats:italic>\n                    and\n                    <jats:italic>p62<\/jats:italic>\n                    expression, LC3-II and p62 (p62 bodies) accumulation and the induction of LC3 puncta. In docetaxel-treated cells, trehalose, but not rapamycin, determined a perinuclear mitochondrial aggregation (mito-aggresomes), and mitochondria specifically colocalized with LC3 and p62-positive autophagosomes. In PC3 cells, rapamycin retained its ability to activate autophagy without evidences of mitophagy even in presence of docetaxel. Interestingly, these results were replicated in LNCaP cells, whereas trehalose and rapamycin did not modify the response to docetaxel in the\n                    <jats:italic>ATG5-<\/jats:italic>\n                    deficient (autophagy resistant) DU145 cells. Therefore, autophagy is involved to alter the response to chemotherapy in combination therapies and the response may be influenced by the different autophagic pathways utilized and by the type of cancer cells.\n                  <\/jats:p>","DOI":"10.1038\/s41419-018-0866-5","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T03:59:54Z","timestamp":1535601594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-846X","authenticated-orcid":false,"given":"Riccardo","family":"Cristofani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Montagnani Marelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Cicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Marzagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Limonta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8883-0468","authenticated-orcid":false,"given":"Angelo","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Manuela","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"key":"866_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/archsurg.1941.01210140043004","volume":"43","author":"C Huggins","year":"1941","unstructured":"Huggins, C. Studies on prostatic cancer. Arch. Surg. 43, 209 (1941).","journal-title":"Arch. Surg."},{"key":"866_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson, P. A., Arora, V. K. & Sawyers, C. L. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat. Rev. Cancer 15, 701\u2013711 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"866_CR3","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ctrv.2015.08.002","volume":"41","author":"C Buttigliero","year":"2015","unstructured":"Buttigliero, C. et al. Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer. Cancer Treat. Rev. 41, 884\u2013892 (2015).","journal-title":"Cancer Treat. Rev."},{"key":"866_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1470-2045(15)70033-1","volume":"16","author":"D Lorente","year":"2015","unstructured":"Lorente, D., Mateo, J., Perez-Lopez, R., de Bono, J. S. & Attard, G. Sequencing of agents in castration-resistant prostate cancer. Lancet Oncol. 16, 279\u2013292 (2015).","journal-title":"Lancet Oncol."},{"key":"866_CR5","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa040720","volume":"351","author":"IF Tannock","year":"2004","unstructured":"Tannock, I. F. et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N. Engl. J. Med. 351, 1502\u20131512 (2004).","journal-title":"N. Engl. J. Med."},{"key":"866_CR6","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa041318","volume":"351","author":"DP Petrylak","year":"2004","unstructured":"Petrylak, D. P. et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N. Engl. J. Med. 351, 1513\u20131520 (2004).","journal-title":"N. Engl. J. Med."},{"key":"866_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","volume":"376","author":"JS De Bono","year":"2010","unstructured":"De Bono, J. S. et al. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial. Lancet 376, 1147\u20131154 (2010).","journal-title":"Lancet"},{"key":"866_CR8","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.7150\/ijbs.11439","volume":"11","author":"W Zhang","year":"2015","unstructured":"Zhang, W., Meng, Y., Liu, N., Wen, X. F. & Yang, T. Insights into chemoresistance of prostate cancer. Int. J. Biol. Sci. 11, 1160\u20131170 (2015).","journal-title":"Int. J. Biol. Sci."},{"key":"866_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.350","volume":"4","author":"X Sui","year":"2013","unstructured":"Sui, X. et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 4, e838 (2013).","journal-title":"Cell Death Dis."},{"key":"866_CR10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature06639","volume":"451","author":"N Mizushima","year":"2008","unstructured":"Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy fights disease through cellular self-digestion. Nature 451, 1069\u20131075 (2008).","journal-title":"Nature"},{"key":"866_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/icb.2014.85","volume":"93","author":"D Denton","year":"2014","unstructured":"Denton, D., Xu, T. & Kumar, S. Autophagy as a pro-death pathway. Immunol. Cell Biol. 93, 35\u201342 (2014).","journal-title":"Immunol. Cell Biol."},{"key":"866_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.15252\/embj.201490784","volume":"34","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi, L. et al. Autophagy in malignant transformation and cancer progression. EMBO J. 34, 856\u2013880 (2015).","journal-title":"EMBO J."},{"key":"866_CR13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/onc.2012.92","volume":"32","author":"Ra Veldhoen","year":"2012","unstructured":"Veldhoen, Ra et al. The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis. Oncogene 32, 736\u2013746 (2012).","journal-title":"Oncogene"},{"key":"866_CR14","doi-asserted-by":"publisher","unstructured":"Tai, C. J. et al. Aqueous extract of solanum nigrum leaves induces autophagy and enhances cytotoxicity of cisplatin, doxorubicin, docetaxel, and 5-fluorouracil in human colorectal carcinoma cells. Evidence-based Complement. Altern. Med. https:\/\/doi.org\/10.1155\/2013\/514719 (2013).","DOI":"10.1155\/2013\/514719"},{"key":"866_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.canlet.2013.10.003","volume":"343","author":"D Kumar","year":"2014","unstructured":"Kumar, D., Shankar, S. & Srivastava, R. K. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K\/Akt\/mTOR signaling pathway. Cancer Lett. 343, 179\u2013189 (2014).","journal-title":"Cancer Lett."},{"key":"866_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbcan.2010.07.003","volume":"1806","author":"S Chen","year":"2010","unstructured":"Chen, S. et al. Autophagy is a therapeutic target in anticancer drug resistance. Biochim. Biophys. Acta\u2014Rev. Cancer 1806, 220\u2013229 (2010).","journal-title":"Biochim. Biophys. Acta\u2014Rev. Cancer"},{"key":"866_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-165","volume":"13","author":"B Pan","year":"2014","unstructured":"Pan, B. et al. HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma. Mol. Cancer 13, 165 (2014).","journal-title":"Mol. Cancer"},{"key":"866_CR18","first-page":"1","volume":"11","author":"YC Su","year":"2016","unstructured":"Su, Y. C. et al. Galectin-1-induced autophagy facilitates cisplatin resistance of hepatocellular carcinoma. PLoS ONE 11, 1\u201314 (2016).","journal-title":"PLoS ONE"},{"key":"866_CR19","unstructured":"Chourasia, A. H., Boland, M. L. & Macleod, K. F. Mitophagy and cancer. Cancer Metab. 3, 4\u2013015\u20130130\u20138; eCollection 2015 (2015).Cancer Metab. 3, 4 (2015)"},{"key":"866_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bj.2015.10.002","volume":"39","author":"A Hjelmeland","year":"2016","unstructured":"Hjelmeland, A. & Zhang, J. Metabolic, autophagic, and mitophagic activities in cancer initiation and progression. Biomed. J. 39, 98\u2013106 (2016).","journal-title":"Biomed. J."},{"key":"866_CR21","doi-asserted-by":"publisher","first-page":"44905","DOI":"10.18632\/oncotarget.6457","volume":"6","author":"SA Gordeev","year":"2015","unstructured":"Gordeev, S. A. et al. mTOR kinase inhibitor pp242 causes mitophagy terminated by apoptotic cell death in E1A-Ras transformed cells. Oncotarget 6, 44905\u201344926 (2015).","journal-title":"Oncotarget"},{"key":"866_CR22","doi-asserted-by":"publisher","unstructured":"Radogna, F. et al. Cell type-dependent ROS and mitophagy response leads to apoptosis or necroptosis in neuroblastoma. Oncogene 1\u201315 https:\/\/doi.org\/10.1038\/onc.2015.455 (2015).","DOI":"10.1038\/onc.2015.455"},{"key":"866_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S1097-2765(04)00148-0","volume":"13","author":"O Kandror","year":"2004","unstructured":"Kandror, O., Bretschneider, N., Kreydin, E., Cavalieri, D. & Goldberg, A. L. Yeast adapt to near-freezing temperatures by STRE\/Msn2,4-dependent induction of trehalose synthesis and certain molecular chaperones. Mol. Cell 13, 771\u2013781 (2004).","journal-title":"Mol. Cell"},{"key":"866_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neulet.2010.03.065","volume":"475","author":"C Gomes","year":"2010","unstructured":"Gomes, C., Escrevente, C. & Costa, J. Mutant superoxide dismutase 1 overexpression in NSC-34 cells: effect of trehalose on aggregation, TDP-43 localization and levels of co-expressed glycoproteins. Neurosci. Lett. 475, 145\u2013149 (2010).","journal-title":"Neurosci. Lett."},{"key":"866_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm985","volume":"10","author":"M Tanaka","year":"2004","unstructured":"Tanaka, M. et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med. 10, 148\u2013154 (2004).","journal-title":"Nat. Med."},{"key":"866_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.nbd.2005.02.003","volume":"20","author":"R Liu","year":"2005","unstructured":"Liu, R., Barkhordarian, H., Emadi, S., Chan, B. P. & Sierks, M. R. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42. Neurobiol. Dis. 20, 74\u201381 (2005).","journal-title":"Neurobiol. Dis."},{"key":"866_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.nbd.2010.05.014","volume":"39","author":"JA Rodr\u00edguez-Navarro","year":"2010","unstructured":"Rodr\u00edguez-Navarro, J. A. et al. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted\/tau overexpressing mice through autophagy activation. Neurobiol. Dis. 39, 423\u2013438 (2010).","journal-title":"Neurobiol. Dis."},{"key":"866_CR28","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/j.neurobiolaging.2013.05.026","volume":"34","author":"P Rusmini","year":"2013","unstructured":"Rusmini, P. et al. Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy. Neurobiol. Aging 34, 2585\u20132603 (2013).","journal-title":"Neurobiol. Aging"},{"key":"866_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuro.2014.07.006","volume":"44","author":"S Sarkar","year":"2014","unstructured":"Sarkar, S. et al. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson\u2019s disease mouse model. Neurotoxicology 44, 250\u2013262 (2014).","journal-title":"Neurotoxicology"},{"key":"866_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/hmg\/ddu419","volume":"24","author":"E Giorgetti","year":"2015","unstructured":"Giorgetti, E. et al. Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy. Hum. Mol. Genet. 24, 64\u201375 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"866_CR31","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1074\/jbc.M609532200","volume":"282","author":"S Sarkar","year":"2007","unstructured":"Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A. & Rubinsztein, D. C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem. 282, 5641\u20135652 (2007).","journal-title":"J. Biol. Chem."},{"key":"866_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep38586","volume":"6","author":"AL Mayer","year":"2016","unstructured":"Mayer, A. L. et al. SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy. Sci. Rep. 6, 38586 (2016).","journal-title":"Sci. Rep."},{"key":"866_CR33","doi-asserted-by":"publisher","first-page":"10040","DOI":"10.1158\/0008-5472.CAN-06-0802","volume":"66","author":"C Cao","year":"2006","unstructured":"Cao, C. et al. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res. 66, 10040\u201310047 (2006).","journal-title":"Cancer Res."},{"key":"866_CR34","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1200\/JCO.2008.20.0766","volume":"27","author":"F Meric-Bernstam","year":"2009","unstructured":"Meric-Bernstam, F. & Gonzalez-Angulo, A. M. Targeting the mTOR signaling network for cancer therapy. J. Clin. Oncol. 27, 2278\u20132287 (2009).","journal-title":"J. Clin. Oncol."},{"key":"866_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2014.01.017","volume":"1553","author":"T Urbanek","year":"2014","unstructured":"Urbanek, T., Kuczmik, W., Basta-Kaim, A. & Gabryel, B. Rapamycin induces of protective autophagy in vascular endothelial cells exposed to oxygen-glucose deprivation. Brain Res. 1553, 1\u201311 (2014).","journal-title":"Brain Res."},{"key":"866_CR36","first-page":"125","volume":"5","author":"H Liao","year":"2015","unstructured":"Liao, H. et al. Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor AZD2014 in hepatocellular carcinoma. Am. J. Cancer Res. 5, 125\u2013139 (2015).","journal-title":"Am. J. Cancer Res."},{"key":"866_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/ERC-12-0394","volume":"20","author":"RL Bitting","year":"2013","unstructured":"Bitting, R. L. & Armstrong, A. J. Targeting the PI3K\/Akt\/mTOR pathway in castration-resistant prostate cancer. Endocr. Relat. Cancer 20, 83\u201399 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"866_CR38","doi-asserted-by":"publisher","unstructured":"Dodurga, Y., Avci, \u00c7. B., Susluer, S. Y., \u015eatiro\u01e7lu Tufan, N. L. & G\u00fcnd\u00fcz, C. The expression of URGCP gene in prostate cancer cell lines: correlation with rapamycin. Mol. Biol. Rep. 1\u20135 https:\/\/doi.org\/10.1007\/s11033-012-1891-6 (2012).","DOI":"10.1007\/s11033-012-1891-6"},{"key":"866_CR39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2967\/jnumed.112.112169","volume":"54","author":"Ra Dumont","year":"2013","unstructured":"Dumont, Ra et al. Targeted radiotherapy of prostate cancer with a gastrin-releasing peptide receptor antagonist is effective as monotherapy and in combination with rapamycin. J. Nucl. Med. 54, 762\u2013769 (2013).","journal-title":"J. Nucl. Med."},{"key":"866_CR40","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbrc.2012.02.089","volume":"419","author":"Y Morikawa","year":"2012","unstructured":"Morikawa, Y. et al. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation. Biochem. Biophys. Res. Commun. 419, 584\u2013589 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"866_CR41","first-page":"1772","volume":"6","author":"A Imrali","year":"2016","unstructured":"Imrali, A., Mao, X., Yeste-Velasco, M., Shamash, J. & Lu, Y. Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatin. Am. J. Cancer Res. 6, 1772\u20131784 (2016).","journal-title":"Am. J. Cancer Res."},{"key":"866_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep28423","volume":"6","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. Trehalose, sucrose and raffinose are novel activators of autophagy in human keratinocytes through an mTOR-independent pathway. Sci. Rep. 6, 28423 (2016).","journal-title":"Sci. Rep."},{"key":"866_CR43","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1080\/15548627.2015.1047130","volume":"11","author":"DL Medina","year":"2015","unstructured":"Medina, D. L. & Ballabio, A. Lysosomal calcium regulates autophagy. Autophagy 11, 970\u2013971 (2015).","journal-title":"Autophagy"},{"key":"866_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for use and interpretation of assays for monitoring autophagy (3rd edition).Autophagy 12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"866_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4161\/auto.22397","volume":"9","author":"DY Ouyang","year":"2013","unstructured":"Ouyang, D. Y. et al. Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5. Autophagy 9, 20\u201332 (2013).","journal-title":"Autophagy"},{"key":"866_CR46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/aps.2013.5","volume":"345","author":"YP Yang","year":"2013","unstructured":"Yang, Y.-P. et al. Application and interpretation of current autophagy inhibitors and activators. Acta Pharmacol. Sin. 345, 625\u2013635 (2013).","journal-title":"Acta Pharmacol. Sin."},{"key":"866_CR47","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4161\/auto.7.2.14181","volume":"7","author":"HM Ni","year":"2011","unstructured":"Ni, H. M. et al. Dissecting the dynamic turnover of GFP-LC3 in the autolysosome. Autophagy 7, 188\u2013204 (2011).","journal-title":"Autophagy"},{"key":"866_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/pros.22737","volume":"74","author":"MA Chang","year":"2014","unstructured":"Chang, M. A. et al. P62\/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines. Prostate 74, 149\u2013163 (2014).","journal-title":"Prostate"},{"key":"866_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-70","volume":"13","author":"K Singh","year":"2014","unstructured":"Singh, K. et al. Autophagic flux determines cell death and survival in response to Apo2L\/TRAIL (dulanermin). Mol. Cancer 13, 70 (2014).","journal-title":"Mol. Cancer"},{"key":"866_CR50","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/15548627.2015.1017182","volume":"11","author":"B Rah","year":"2015","unstructured":"Rah, B. et al. PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells. Autophagy 11, 314\u2013331 (2015).","journal-title":"Autophagy"},{"key":"866_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-15-1","volume":"15","author":"JY Jeon","year":"2015","unstructured":"Jeon, J. Y., Kim, S. W., Park, K. C. & Yun, M. The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells. Bmc Cancer 15, 1\u201310 (2015).","journal-title":"Bmc Cancer"},{"key":"866_CR52","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s10495-016-1275-9","volume":"21","author":"O Berrak","year":"2016","unstructured":"Berrak, O., Arisan, E. D., Obakan-Yerlikaya, P., Coker-G\u00fcrkan, A. & Palavan-Unsal, N. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K\/AKT\/mTOR signaling axis in prostate cancer cells. Apoptosis 21, 1158\u20131178 (2016).","journal-title":"Apoptosis"},{"key":"866_CR53","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.eururo.2013.07.022","volume":"65","author":"JM Fitzpatrick","year":"2014","unstructured":"Fitzpatrick, J. M. & De Wit, R. Taxane mechanisms of action: potential implications for treatment sequencing in metastatic castration-resistant prostate cancer. Eur. Urol. 65, 1198\u20131204 (2014).","journal-title":"Eur. Urol."},{"key":"866_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.phrs.2015.08.022","volume":"102","author":"MC Caino","year":"2015","unstructured":"Caino, M. C. & Altieri, D. C. Disabling mitochondrial reprogramming in cancer. Pharmacol. Res. 102, 42\u201345 (2015).","journal-title":"Pharmacol. Res."},{"key":"866_CR55","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.molcel.2008.08.002","volume":"31","author":"C Sheridan","year":"2008","unstructured":"Sheridan, C., Delivani, P., Cullen, S. P. & Martin, S. J. Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome c release. Mol. Cell 31, 570\u2013585 (2008).","journal-title":"Mol. Cell"},{"key":"866_CR56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4161\/auto.7.3.14502","volume":"7","author":"K Wang","year":"2011","unstructured":"Wang, K. & Klionsky, D. J. Mitochondria removal by autophagy. Autophagy 7, 297\u2013300 (2011).","journal-title":"Autophagy"},{"key":"866_CR57","first-page":"1","volume":"3","author":"KF Macleod","year":"2013","unstructured":"Macleod, K. F., Boland, M. L., Chourasia, A. H. & Macleod, K. F. Mitochondrial dysfunction in cancer mitochondrial dysfunction in cancer. Front. Oncol. 3, 1\u201328 (2013).","journal-title":"Front. Oncol."},{"key":"866_CR58","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.4161\/auto.24001","volume":"9","author":"NJ Dolman","year":"2013","unstructured":"Dolman, N. J., Chambers, K. M., Mandavilli, B., Batchelor, R. H. & Janes, M. S. Tools and techniques to measure mitophagy using fluorescence microscopy. Autophagy 9, 1653\u20131662 (2013).","journal-title":"Autophagy"},{"key":"866_CR59","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.canlet.2011.09.034","volume":"314","author":"Y Xu","year":"2012","unstructured":"Xu, Y. et al. Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer Lett. 314, 232\u2013243 (2012).","journal-title":"Cancer Lett."},{"key":"866_CR60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/ced.12138","volume":"38","author":"TJ Wright","year":"2013","unstructured":"Wright, T. J. et al. Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase\/AKT signalling and autophagy. Clin. Exp. Dermatol. 38, 421\u2013423 (2013).","journal-title":"Clin. Exp. Dermatol."},{"key":"866_CR61","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.4161\/auto.28984","volume":"10","author":"MR Rosenfeld","year":"2014","unstructured":"Rosenfeld, M. R. et al. A phase I \/ II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme A phase I \/ II trial of hydroxychloroquine in conjunction with radiation the. Autophagy 10, 1359\u20131368 (2014).","journal-title":"Autophagy"},{"key":"866_CR62","first-page":"1","volume":"5","author":"F Zhang","year":"2014","unstructured":"Zhang, F. et al. Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival. Nat. Commun. 5, 1\u201313 (2014).","journal-title":"Nat. Commun."},{"key":"866_CR63","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00210-015-1104-7","volume":"388","author":"RD Pickard","year":"2015","unstructured":"Pickard, R. D. et al. Paradoxical effects of the autophagy inhibitor 3-methyladenine on docetaxel-induced toxicity in PC-3 and LNCaP prostate cancer cells. Naunyn Schmiede. Arch. Pharmacol. 388, 793\u2013799 (2015).","journal-title":"Naunyn Schmiede. Arch. Pharmacol."},{"key":"866_CR64","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/jcp.21522","volume":"217","author":"F Fabbri","year":"2008","unstructured":"Fabbri, F. et al. Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells. J. Cell. Physiol. 217, 494\u2013501 (2008).","journal-title":"J. Cell. Physiol."},{"key":"866_CR65","doi-asserted-by":"crossref","unstructured":"Zhang, J. et al. Docetaxel enhances lysosomal function through TFEB activation. Cell Death Dis. 9, 614 (2018).","DOI":"10.1038\/s41419-018-0571-4"},{"key":"866_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-126","volume":"10","author":"AJ O\u2019Neill","year":"2011","unstructured":"O\u2019Neill, A. J. et al. Characterisation and manipulation of docetaxel resistant prostate cancer cell lines. Mol. Cancer 10, 126 (2011).","journal-title":"Mol. Cancer"},{"key":"866_CR67","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.yexcr.2012.01.027","volume":"318","author":"F Strappazzon","year":"2012","unstructured":"Strappazzon, F., Campello, S. & Cecconi, F. Non-apoptotic roles for death-related molecules: When mitochondria chose cell fate. Exp. Cell Res. 318, 1309\u20131315 (2012).","journal-title":"Exp. Cell Res."},{"key":"866_CR68","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00018-015-2087-8","volume":"73","author":"A Hamacher-Brady","year":"2016","unstructured":"Hamacher-Brady, A. & Brady, N. R. Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy. Cell. Mol. Life Sci. 73, 775\u2013795 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"866_CR69","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/1541-7786.MCR-10-0445","volume":"9","author":"V Choudhary","year":"2011","unstructured":"Choudhary, V. et al. Novel role of androgens in mitochondrial fission and apoptosis. Mol. Cancer Res. 9, 1067\u20131077 (2011).","journal-title":"Mol. Cancer Res."},{"key":"866_CR70","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/15548627.2016.1166318","volume":"12","author":"Q Huang","year":"2016","unstructured":"Huang, Q. et al. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy 12, 999\u20131014 (2016).","journal-title":"Autophagy"},{"key":"866_CR71","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1083\/jcb.201001039","volume":"189","author":"JY Lee","year":"2010","unstructured":"Lee, J. Y., Nagano, Y., Taylor, J. P., Lim, K. L. & Yao, T. P. Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J. Cell. Biol. 189, 671\u2013679 (2010).","journal-title":"J. Cell. Biol."},{"key":"866_CR72","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/cdd.2014.139","volume":"22","author":"F Strappazzon","year":"2015","unstructured":"Strappazzon, F. et al. AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62\/SQSTM1. Cell Death Differ. 22, 419\u2013432 (2015).","journal-title":"Cell Death Differ."},{"key":"866_CR73","doi-asserted-by":"crossref","unstructured":"Del Bello, B., Toscano, M., Moretti, D. & Maellaro, E. Cisplatin-induced apoptosis inhibits autophagy, which acts as a pro-survival mechanism in human melanoma cells. PLoS ONE 8, 1\u201314 (2013).","DOI":"10.1371\/annotation\/8551e3d5-fdd5-413b-a253-170ba13b7525"},{"key":"866_CR74","doi-asserted-by":"publisher","first-page":"33889","DOI":"10.1074\/jbc.273.51.33889","volume":"273","author":"N Mizushima","year":"1998","unstructured":"Mizushima, N., Sugita, H., Yoshimori, T. & Ohsumi, Y. A new protein conjugation in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy. J. Biol. Chem. 273, 33889\u201333892 (1998).","journal-title":"J. Biol. Chem."},{"key":"866_CR75","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fncel.2013.00234","volume":"7","author":"V Crippa","year":"2013","unstructured":"Crippa, V. et al. Differential autophagy power in the spinal cord and muscle of transgenic ALS mice. Front. Cell. Neurosci. 7, 234 (2013).","journal-title":"Front. Cell. Neurosci."},{"key":"866_CR76","first-page":"1","volume":"0","author":"V Crippa","year":"2016","unstructured":"Crippa, V. et al. The chaperone HSPB8 reduces the accumulation of truncated TDP-43 species in cells and protects against TDP-43-mediated toxicity. Hum. Mol. Genet. 0, 1\u201317 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"866_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2017.1308985","volume":"13","author":"R Cristofani","year":"2017","unstructured":"Cristofani, R. et al. Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases. Autophagy 13, 1\u201324 (2017).","journal-title":"Autophagy"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0866-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0866-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0866-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:08:09Z","timestamp":1671520089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0866-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":77,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0866-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,30]]},"assertion":[{"value":"20 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"889"}}